Literature DB >> 22901271

The role of waixenicin A as transient receptor potential melastatin 7 blocker.

Byung J Kim1, Joo H Nam, Young K Kwon, Insuk So, Seon J Kim.   

Abstract

Transient receptor potential melastatin 7 (TRPM7) plays a role in a number of physiological and pharmacological functions in variety of cells. The aim of this study was to clarify the role for TRPM7 channels and the effect of waixenicin A on the pacemaking activity of interstitial cells of Cajal (ICCs) and on the cell viability of the human gastric and breast adenocarcinoma cell lines, AGS and MCF-7, respectively. Waixenicin A decreased the amplitude of pacemaker potentials in cultured ICC clusters and inhibited TRPM7 currents, but had no effect on Ca(2+) -activated Cl(-) conductance (ANO1). Furthermore, waixenicin A was found to inhibit the growth and survival of AGS and MCF-7 cells. These findings indicate that TRPM7 channel modulates intestinal motility and regulates the pathophysiology of human gastric and breast adenocarcinoma cells. These findings suggest that TRPM7 channel be considered a potential target for the treatment of gut motor disorders and gastric and breast cancer.
© 2012 The Authors Basic & Clinical Pharmacology & Toxicology © 2012 Nordic Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901271     DOI: 10.1111/j.1742-7843.2012.00929.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  17 in total

1.  TRPM7 triggers Ca2+ sparks and invadosome formation in neuroblastoma cells.

Authors:  Daan Visser; Michiel Langeslag; Katarzyna M Kedziora; Jeffrey Klarenbeek; Alwin Kamermans; F David Horgen; Andrea Fleig; Frank N van Leeuwen; Kees Jalink
Journal:  Cell Calcium       Date:  2013-10-16       Impact factor: 6.817

Review 2.  Transient Receptor Potential Channels in Microglia: Roles in Physiology and Disease.

Authors:  Santiago Echeverry; María Juliana Rodriguez; Yolima P Torres
Journal:  Neurotox Res       Date:  2016-06-03       Impact factor: 3.911

Review 3.  Calcium influx pathways in breast cancer: opportunities for pharmacological intervention.

Authors:  I Azimi; S J Roberts-Thomson; G R Monteith
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

4.  Sphingosine and FTY720 modulate pacemaking activity in interstitial cells of Cajal from mouse small intestine.

Authors:  Joo Hyun Nam; Woo Kyung Kim; Byung Joo Kim
Journal:  Mol Cells       Date:  2013-08-02       Impact factor: 5.034

Review 5.  New insights into pharmacological tools to TR(i)P cancer up.

Authors:  M Gautier; I Dhennin-Duthille; A S Ay; P Rybarczyk; I Korichneva; H Ouadid-Ahidouch
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

6.  TRPM7 maintains progenitor-like features of neuroblastoma cells: implications for metastasis formation.

Authors:  Jeroen Middelbeek; Daan Visser; Linda Henneman; Alwin Kamermans; Arthur J Kuipers; Peter M Hoogerbrugge; Kees Jalink; Frank N van Leeuwen
Journal:  Oncotarget       Date:  2015-04-20

Review 7.  Natural and Synthetic Modulators of the TRPM7 Channel.

Authors:  Vladimir Chubanov; Sebastian Schäfer; Silvia Ferioli; Thomas Gudermann
Journal:  Cells       Date:  2014-11-27       Impact factor: 6.600

Review 8.  Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target.

Authors:  Nelson S Yee
Journal:  Pharmaceuticals (Basel)       Date:  2017-04-05

9.  Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.

Authors:  Xianping Che; Jiangtao Zhan; Fan Zhao; Zunhe Zhong; Mianchuan Chen; Ruifa Han; Yi Wang
Journal:  Biomed Res Int       Date:  2021-07-05       Impact factor: 3.411

10.  Cellular and Developmental Biology of TRPM7 Channel-Kinase: Implicated Roles in Cancer.

Authors:  Nelson S Yee; Abid A Kazi; Rosemary K Yee
Journal:  Cells       Date:  2014-07-30       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.